Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 2020-009-A
On April 29, 2020, the FDA issued Circular No. 009-B-20, which amends the previous guidelines related to medical devices during the COVID-19 public health emergency. The amendment includes "Respiratory Therapy Devices" in the list of health products subject to regulatory oversight. The updated list now encompasses various protective gear, diagnostic kits, and respiratory support equipment, such as ventilators and respirators. This circular is effective immediately and aims to enhance the identification and evaluation of health products in response to the pandemic.
Law Information
- Reference Number
- FDA Circular No. 009-B-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
April 29, 2020
FDA CIRCULAR NO. 009-B-20
| SUBJECT | : | Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 2020-009-A |
The listing of health products enumerated under Section IV-Scope of FDA Circular No. 2020-009, as amended by FDA Circular No. 2020-009-A, entitled "Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to Address COVID-19 Public Health Emergency is hereby amended to include "Respiratory Therapy Devices."
Therefore, the listing provided under said Section of the subject Circular shall be amended to read as follows: HTcADC
1. Face Masks including N-95 Masks,
2. Shoe Covers,
3. Gloves,
4. Head Covers,
5. Gowns,
6. Goggles/Face Shields,
7. COVID-19 Diagnostic Test Kits,
8. Alcohol, Hand Sanitizers, etc.,
9. Ventilators, Respirators, their respective Accessories, and Respiratory Therapy Devices,
10. Other health products that may hereinafter identified and listed by the FDA.
This issuance shall take effect immediately.
For your information and guidance.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, MDDirector General
Cite This Law
Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 2020-009-A, FDA Circular No. 009-B-20, Apr 29, 2020 (Philippines)
Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 2020-009-A, FDA Circular No. 009-B-20 (Phil. 2020)
Related Laws
- FDA Clearance of Respiratory Therapy Devices Prior Customs ReleaseFDA Advisory No. 2020-761 • Apr 29, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Amendment to FDA Circular No. 2020-005 re: Prohibition on the Online Selling of Essential Emergency Medical Supplies beyond the Price Ceiling/Range set by Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-AFDA Circular No. 005-A-20 • Mar 20, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Amendment to FDA Memorandum Circular No. 2020-001FDA Memorandum Circular No. 001-A-20 • Apr 16, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Prohibition on the Selling of Essential Emergency Medicines and Medical Devices Beyond the Price Ceiling/Range Set by the Department Memorandum No. 2020-0058FDA Circular No. 017-20 • May 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Interim Guidelines of the Importation and Manufacture of Personal Protective Equipment (PPE), Ventilators and Respirators to be Used in the COVID-19 PandemicFDA Circular No. 018-20 • May 26, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Prohibition on the Online Selling of Essential Emergency Medical Supplies beyond the Price Ceiling/Range set by Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-AFDA Circular No. 005-20 • Mar 12, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law